ParkerHannifin Partners with phaware to Combat Meth-Associated Pulmonary Hypertension Crisis
- ParkerHannifin supports the phaware podcast series to raise awareness about methamphetamine-associated pulmonary hypertension (Meth-PAH).
- The company aims to enhance public health by engaging in discussions on respiratory illnesses and their impact.
- ParkerHannifin’s mission includes improving quality of life through innovative technologies and health initiatives related to Meth-PAH.
ParkerHannifin Joins the Fight Against Meth-Associated Pulmonary Hypertension
ParkerHannifin, a leader in motion and control technologies, recognizes the urgent health crisis posed by methamphetamine-associated pulmonary hypertension (Meth-PAH) in the United States. The recent launch of the phaware® global association's podcast series, “I’m Aware That I’m Rare,” offers a vital platform for discussing this pressing issue, which has garnered increasing attention from healthcare professionals and advocates alike. This six-part series, kicking off on September 16, 2025, coincides with the 10th season of the podcast and leads into Pulmonary Hypertension Awareness Month, highlighting the dire need for awareness and education surrounding Meth-PAH.
The discussions within the podcast feature prominent physicians and patients sharing their insights on critical topics such as addiction, stigma, and resilience in the context of Meth-PAH. Dr. John Kingrey, one of the featured experts, emphasizes the alarming national surge in Meth-PAH cases and the necessity for compassionate care approaches. By addressing the complexities of this health crisis, the series aims to foster a deeper understanding of Meth-PAH, its impact on individuals and families, and the systemic barriers that prevent effective treatment. This dialogue is not only timely but essential, as it seeks to break down the stigma surrounding the condition and promote a more inclusive environment for those affected.
In addition to Dr. Kingrey, the podcast includes contributions from experts like Dr. Vinicio de Jesus Perez, who discusses the evolving demographics of methamphetamine use, and Dr. Peter Leary, who focuses on how societal stigma complicates access to treatment. Personal narratives, such as that of patient Anthony Carrasco, who shares his journey from addiction to recovery and lung transplant, serve to humanize the statistics and illuminate the resilience of individuals battling this condition. Steve Van Wormer, president of phaware, underscores the importance of these conversations in addressing urgent care needs and fostering a culture of understanding and support for those affected by Meth-PAH.
In parallel, ParkerHannifin’s commitment to health and wellness aligns with initiatives like those presented in the phaware podcast series. By supporting research and engaging in community discussions around respiratory illnesses and their implications, the company aims to contribute positively to public health efforts. This partnership in raising awareness about Meth-PAH reflects ParkerHannifin's broader mission to enhance the quality of life through innovative technologies and collaborative health initiatives.
Related Cashu News

Lockheed Martin Advances AI, Autonomy, and Space Exploration for Enhanced Military Operations and Safety
Lockheed Martin (Ticker: LMT) is making significant strides in integrating artificial intelligence and autonomy to enhance the efficiency and safety of military operations. The company focuses on deve…

AeroVironment Reports 133% Revenue Growth Amid Rising Military Demand for UAVs
AeroVironment (Ticker: AVAV) has emerged as a leader in the unmanned aerial vehicle (UAV) industry, particularly amidst a heightened global focus on defense technologies. The company has achieved subs…

AZZ Inc. Earnings Report Could Impact Stock Volatility and Dividend Investor Sentiment
AZZ Inc. (Ticker: AZZ) positions itself strongly in the industrial sector with its upcoming earnings report, reflecting its financial health and dividend strategy. Scheduled for release on July 8, the…

Astronics Signs Long-Term Deal with Vertical Aerospace for Valo eVTOL Power Systems
In late June 2026, Vertical Aerospace establishes a long-term agreement with Astronics Corporation (Ticker: ATRO) to supply the low-voltage power distribution system for its Valo eVTOL aircraft. This…

